Erin Winstanley , PhD

Associate Professor

Organization:

West Virginia University School of Pharmacy

Department:

Pharmaceutical Systems & Policy

Classification:

Faculty

• PhD, The Johns Hopkins Bloomberg School of Public Health, 2006

Winstanley EL, Burtchin M, Zhang Y, Campbell P, Pahl J, Beck S, Bohenek W. Inpatient experiences with MyChart Bedside. Telemedicine and e-Health in press.

Winstanley EL, Mashni R, Schnee S, Miller N, Mashni S. The development and feasibility of a pharmacist-delivered opioid intervention in the emergency department. Journal of the American Pharmacists Association in press.

Winstanley EL, Clark A, Feinberg J, Wilder CM. Implementation of opioid overdose prevention programs: A case report from Ohio. Substance Abuse 2016; 37(1): 42-6. 

Winstanley EL. Tangled-Up & Blue: Releasing the Regulatory Chokehold on Take-Home Naloxone. Addiction 2016; 111(4): 583-4.

Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, Lyons MS. ED Prescription opioids as an initial exposure preceding addiction. Annals of Emergency Medicine 2016; 68(2): 202-8.

Clark A, Winstanley EL, Martsolf DS, Rosen M. Implementation of an inpatient opioid overdose prevention program. Addictive Behaviors 2016; 53:141-5.

Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. Journal of Addictive Diseases 2016; 35(1): 42-51.

Rosa C, Campbell ANC, Miele G, Brunner M, Winstanley EL. Using E-Technologies in Clinical Trials. Contemporary Clinical Trials 2015; 45: 41-54.

Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving Beyond Misuse and Diversion: The Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic. American Journal of Public Health 2014 Sep 11: e1-e7.

Clark A, Wilder CM, Winstanley EL. 2014. A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs. Journal of Addiction Medicine 2014; 8(3): 153-63.

Winstanley EL, Brigham GS, Babcock D, Winhusen T. Improving treatment for opioid dependence: A perspective from the Ohio Valley Node of the NIDA Clinical Trials Network. Progress in Community Health Partnerships: Research, Education, and Action 2014; 8(1): 99-107.

Winstanley EL, Gay J, Roberts L, Moseley J, Hall O, Beeghly BC, Winhusen T, Somoza E. Prescription Drug Abuse as a Public Health Problem: A Case Report from Ohio. Public Health Nursing 2012; 29(6): 553-562. PMID: 23078426

Winstanley EL, Steinwachs DM, Stitzer ML, Fishman MJ. Adolescent Substance Abuse and Mental Health: Problem Co-occurrence and Access to Services. Journal of Child & Adolescent Substance Abuse 2012; 21:310-322. 

Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of Opioid Dependence in Adolescents and Young Adults with Extended Release Naltrexone: Preliminary Case Series and Feasibility. Addiction 2010; 105(9):1669-76. PMID: 20626723

Babor TF, Winstanley EL. The World of Drinking: National Alcohol Control Experiences in 18 Countries. Addiction 2008;103(5): 721-5. PMID:18412749

Winstanley EL, Steinwachs DM, Ensminger ME, Latkin CA, Stitzer M L, Olsen Y. The Association of Neighborhood Disorganization and Social Capital with Adolescent Alcohol and Drug Use, Dependence, and Access to Treatment. Drug and Alcohol Dependence 2008; 92/1-3: 173-182. PMID:17913396

Winstanley EL, Gust SW, Strathdee SA. Drug abuse and HIV/AIDS: International Research Lessons and Imperatives. Drug and Alcohol Dependence 2006; 82,1: S1-S5. PMID: 16769437

Dr. Winstanley has over 18 years of experience as a behavioral health services researcher. Her current research is focused on reducing the morbidity and mortality associated with the opioid epidemic, as well as the use of technology to improve access and quality of behavioral health services. Dr. Winstanley is a Co-Investigator on a Centers for Disease Control and Prevention (CDC) grant to conduct an epidemiological study of Hepatitis C among people that inject drugs in suburban and rural areas. Dr. Winstanley has experience working with large datasets including data from prescription drug monitoring programs (PDMPs), electronic health records (Epic) and community-based surveys (NHSDUH). Prior to joining WVU, Dr. Winstanley was an Assistant Professor at the University of Cincinnati and the Director of Health Services Research for Mercy Health.